Quality of Life and Patient-Reported Side Effects of Low-Dose Oral Minoxidil in Treating Female Pattern Hair Loss

    February 2026 in “ PubMed
    Divija Sharma, Lillian Mo, Deep Patel, Austin J. Piontkowski, Candice Medina, Kelly Hawkins, Neda Shokrian, Benjamin Ungar
    Image
    Studysummary This study found that among women with female pattern hair loss, low-dose oral minoxidil improved hair loss severity and quality of life scores despite 71.6% experiencing mild to moderate unwanted hair growth, which most patients did not consider a reason to discontinue treatment. Our plain-language summary of this paper — not a Tressless recommendation.
    A study involving 102 women with female pattern hair loss (FPHL) assessed the impact of low-dose oral minoxidil (LDOM) on quality of life and side effects. Over a median of 12 months, hair loss severity improved significantly, and quality of life scores increased from 67 to 39. Although 71.6% of participants experienced unwanted hair growth, primarily on the face, arms, and legs, 93.2% did not find it a reason to stop treatment, as most cases were mild or moderate. The study concludes that LDOM offers clinical and quality of life improvements, presenting a favorable treatment option for FPHL.
    Discuss this study in the Community →